{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:55:19Z","timestamp":1790906119045,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.emc.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:19:09Z","timestamp":1779103149000},"page":"775-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of the Critically Ill Patient with Opioid Use Disorder"],"prefix":"10.1016","volume":"44","author":[{"given":"Nicholas S.","family":"Imperato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2026.04.010_bib1","unstructured":"SAMHSA. Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 2024. Available at: https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-annual-national-report."},{"key":"10.1016\/j.emc.2026.04.010_bib2","author":"Das"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after non-fatal opioid overdose: reduced mortality risk in medicare disability beneficiaries","volume":"65","author":"Samples","year":"2023","journal-title":"Am J Prev Med"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.emc.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1377\/hlthaff.2024.00984","article-title":"Medicaid patients with ED visits for overdose: disparities in initiation of medications for opioid use disorder","volume":"44","author":"Nguyen","year":"2025","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.emc.2026.04.010_bib6","article-title":"Synthetic opioids have disrupted conventional wisdom for treating opioid overdose","volume":"12","author":"Skolnick","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"4","key":"10.1016\/j.emc.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib9","article-title":"Management of patients with opioid use disorder (OUD)","volume":"17","author":"Martin-Orr","year":"2025","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.emc.2026.04.010_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.annemergmed.2025.01.022","article-title":"Risk of delayed intubation after presumed opioid overdose in the emergency department","volume":"85","author":"McCabe","year":"2025","journal-title":"Ann Emerg Med"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/1742-6723.13418","article-title":"End-tidal capnography provides reliable ventilatory monitoring for non-intubated patients presenting after sedative overdose to the emergency department","volume":"32","author":"Millane","year":"2020","journal-title":"Emerg Med Australas EMA"},{"key":"10.1016\/j.emc.2026.04.010_bib12","series-title":"StatPearls","article-title":"Naloxone","author":"Jordan","year":"2025"},{"issue":"3","key":"10.1016\/j.emc.2026.04.010_bib13","first-page":"492","article-title":"Intravenous buprenorphine reversed opioid-induced respiratory depression without precipitating withdrawal in emergency department patients","volume":"87","author":"Spadaro","year":"2025","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.emc.2026.04.010_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2024.110263","article-title":"The association of early naloxone use with outcomes in non-shockable out-of-hospital cardiac arrest","volume":"201","author":"Strong","year":"2024","journal-title":"Resuscitation"},{"issue":"16_suppl_2","key":"10.1016\/j.emc.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.1161\/CIR.0000000000001369","article-title":"Part 7: adult basic life support: 2025 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"152","author":"Kleinman","year":"2025","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13181-019-00735-w","article-title":"Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl","volume":"16","author":"Carpenter","year":"2020","journal-title":"J Med Toxicol"},{"issue":"7","key":"10.1016\/j.emc.2026.04.010_bib18","article-title":"The double-edged sword: naloxone-induced noncardiogenic pulmonary edema","volume":"15","author":"Marsalisi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.emc.2026.04.010_bib19","doi-asserted-by":"crossref","first-page":"e929412","DOI":"10.12659\/AJCR.929412","article-title":"Naloxone-induced acute pulmonary edema is dose-dependent: a case series","volume":"22","author":"Al-Azzawi","year":"2021","journal-title":"Am J Case Rep"},{"issue":"6","key":"10.1016\/j.emc.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/15563650.2025.2500601","article-title":"Clinical characteristics of patients exposed to medetomidine in the illicit opioid drug supply in Philadelphia - a case series","volume":"63","author":"Murphy","year":"2025","journal-title":"Clin Toxicol Phila Pa"},{"key":"10.1016\/j.emc.2026.04.010_bib21","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7415a1","article-title":"Overdoses involving medetomidine mixed with opioids \u2014 chicago, Illinois, May 2024","volume":"74","author":"Nham","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.emc.2026.04.010_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ajem.2021.06.023","article-title":"Sedation - effects of disorders of abuse on therapeutic efficacy (SEDATE): a retrospective cohort study","volume":"49","author":"Albala","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.emc.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ACO.0000000000001157","article-title":"Perioperative anesthetic management of opioid tolerant patients and patients with active and medically treated Opioid Use Disorder (OUD)","volume":"35","author":"Burns","year":"2022","journal-title":"Curr Opin Anaesthesiol"},{"issue":"6","key":"10.1016\/j.emc.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nurpra.2017.04.016","article-title":"Acute pain management in opioid-tolerant individuals","volume":"13","author":"Cooney","year":"2017","journal-title":"J Nurse Pract"},{"issue":"11","key":"10.1016\/j.emc.2026.04.010_bib25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1513\/AnnalsATS.202005-554CME","article-title":"Management of sedation and analgesia in critically ill patients receiving long-acting naltrexone therapy for opioid use disorder","volume":"17","author":"Petri","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.emc.2026.04.010_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajem.2022.05.013","article-title":"Buprenorphine precipitated opioid withdrawal: prevention and management in the ED setting","volume":"58","author":"Spadaro","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.emc.2026.04.010_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35895","article-title":"Buprenorphine-precipitated withdrawal among hospitalized patients using fentanyl","volume":"7","author":"Thakrar","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.emc.2026.04.010_bib29","series-title":"StatPearls","article-title":"Buprenorphine","author":"Kumar","year":"2025"},{"issue":"10","key":"10.1016\/j.emc.2026.04.010_bib30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/jamainternmed.2024.3977","article-title":"Buprenorphine for opioid use disorder\u2014an essential medical treatment","volume":"184","author":"Weimer","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.emc.2026.04.010_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201dbuprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/15563650.2018.1437921","article-title":"Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal","volume":"56","author":"Surmaitis","year":"2018","journal-title":"Clin Toxicol"},{"issue":"5","key":"10.1016\/j.emc.2026.04.010_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/00000542-199805000-00004","article-title":"Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification","volume":"88","author":"Kienbaum","year":"1998","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.emc.2026.04.010_bib34","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.emc.2026.04.010_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.20702","article-title":"Extended-release 7-Day injectable buprenorphine for patients with minimal to mild opioid withdrawal","volume":"7","author":"D\u2019Onofrio","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.emc.2026.04.010_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.15288\/jsad.24-00099","article-title":"Parenteral buprenorphine for opioid withdrawal: a case series","volume":"86","author":"Spadaro","year":"2025","journal-title":"J Stud Alcohol Drugs"},{"issue":"2","key":"10.1016\/j.emc.2026.04.010_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.chest.2023.10.024","article-title":"Management of critically ill patients receiving medications for opioid use disorder","volume":"165","author":"Erstad","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.emc.2026.04.010_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108869","article-title":"Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone","volume":"226","author":"Agin-Liebes","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/jcph.2286","article-title":"Buprenorphine continuation during critical illness associated with decreased inpatient opioid use in individuals maintained on buprenorphine for opioid use disorder in a retrospective study","volume":"63","author":"Quaye","year":"2023","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.emc.2026.04.010_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/TCRM.S262843","article-title":"Safe use of opioids in chronic kidney disease and hemodialysis patients: tips and tricks for non-pain specialists","volume":"16","author":"Coluzzi","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"10.1016\/j.emc.2026.04.010_bib41","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.32636","article-title":"Opioid drugs in patients with liver disease: a systematic review","volume":"16","author":"Soleimanpour","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.emc.2026.04.010_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109401","article-title":"Undetected respiratory depression in people with opioid use disorder","volume":"234","author":"Tas","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"22","key":"10.1016\/j.emc.2026.04.010_bib43","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-Interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.emc.2026.04.010_bib44","series-title":"StatPearls","article-title":"Methadone","author":"Durrani","year":"2025"},{"key":"10.1016\/j.emc.2026.04.010_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ajem.2024.12.059","article-title":"Emergency department utilization of the methadone \u201c72-hour rule\u201d to bridge or initiate and link to outpatient treatment","volume":"89","author":"Huo","year":"2025","journal-title":"Am J Emerg Med"},{"issue":"21","key":"10.1016\/j.emc.2026.04.010_bib46","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.2024.16954","article-title":"Buprenorphine\/Naloxone vs methadone for the treatment of opioid use disorder","volume":"332","author":"Nosyk","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.emc.2026.04.010_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/ADM.0000000000001324","article-title":"Piloting a hospital based rapid methadone initiation protocol for fentanyl","volume":"18","author":"Liu","year":"2024","journal-title":"J Addiction Med"},{"issue":"1","key":"10.1016\/j.emc.2026.04.010_bib48","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1186\/s40064-016-3757-1","article-title":"Nephrotoxicity of methadone: a systematic review","volume":"5","author":"Alinejad","year":"2016","journal-title":"SpringerPlus"},{"issue":"3","key":"10.1016\/j.emc.2026.04.010_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1755-5922.12120","article-title":"Methadone therapy in underserved urban community: QTc prolongation and life-threatening ventricular arrhythmias","volume":"33","author":"Chowdhury","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"10.1016\/j.emc.2026.04.010_bib50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiol Clin"},{"issue":"9","key":"10.1016\/j.emc.2026.04.010_bib51","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1345\/aph.1R132","article-title":"Impact of enteral methadone on the ability to wean off continuously infused opioids in critically ill, mechanically ventilated adults: a case-control study","volume":"46","author":"Al-Qadheeb","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.emc.2026.04.010_bib52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ADM.0000000000000929","article-title":"Synergistic effect of ketamine and buprenorphine observed in the treatment of buprenorphine precipitated opioid withdrawal in a patient with fentanyl use","volume":"16","author":"Hailozian","year":"2022","journal-title":"J Addiction Med"},{"key":"10.1016\/j.emc.2026.04.010_bib53","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7415a3","article-title":"Notes from the field: severe medetomidine withdrawal syndrome in patients using illegally manufactured opioids \u2014 pittsburgh, Pennsylvania, October 2024\u2013March 2025","volume":"74","author":"Ostrowski","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"10.1016\/j.emc.2026.04.010_bib54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.15585\/mmwr.mm7415a2","article-title":"Notes from the field: suspected medetomidine withdrawal syndrome among fentanyl-exposed patients \u2014 philadelphia, Pennsylvania, September 2024\u2013January 2025","volume":"74","author":"Huo","year":"2025","journal-title":"Morb Mortal Wkly Rep"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862726000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862726000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:17:50Z","timestamp":1790903870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862726000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0733862726000398"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2026.04.010","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the Critically Ill Patient with Opioid Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}